First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Stock Price Passes Above 50 Day Moving Average – What’s Next?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $170.96 and traded as high as $172.80. First Trust NYSE Arca Biotechnology Index Fund shares last traded at $172.67, with a volume of 19,208 shares.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.8 %

The firm has a 50 day moving average of $170.96 and a 200 day moving average of $163.65. The firm has a market cap of $1.30 billion, a price-to-earnings ratio of 17.20 and a beta of 0.86.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Several large investors have recently added to or reduced their stakes in FBT. International Assets Investment Management LLC grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 17,093.0% during the third quarter. International Assets Investment Management LLC now owns 185,512 shares of the company’s stock worth $31,895,000 after purchasing an additional 184,433 shares during the period. Csenge Advisory Group boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 142.6% in the second quarter. Csenge Advisory Group now owns 45,427 shares of the company’s stock worth $6,995,000 after acquiring an additional 26,703 shares in the last quarter. D.A. Davidson & CO. boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 60.9% in the third quarter. D.A. Davidson & CO. now owns 60,339 shares of the company’s stock worth $10,374,000 after acquiring an additional 22,829 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 3,463.2% in the third quarter. Benjamin Edwards Inc. now owns 21,201 shares of the company’s stock worth $3,645,000 after acquiring an additional 20,606 shares in the last quarter. Finally, Assetmark Inc. boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 235.8% in the third quarter. Assetmark Inc. now owns 28,452 shares of the company’s stock worth $4,892,000 after acquiring an additional 19,978 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.